Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page
- Check7 days agoChange DetectedThe phrase 'This study has 1 location' has been added, while the previous version with a comma has been removed.SummaryDifference0.4%
- Check8 days agoChange DetectedThe website has added a new feature to display the 'Last Update Posted', replacing the previous 'Last Update Posted (Estimated)' information.SummaryDifference0.0%
- Check15 days agoChange DetectedNew updates for November 2024 have been added, including an estimated last update date, while several previous dates and detailed participant and intervention information have been removed.SummaryDifference4%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.